Boston Scientific Corp. shares fell nearly 7 percent Friday on news that the company had received an warning letter from the U.S. Food and Drug Administration and that recently acquired Guidant Corp.'s earnings had fallen sharply.
http://c.moreover.com/click/here.pl?r458629177
http://c.moreover.com/click/here.pl?r458629177